Coronary Stents Market Projected to Reach US$ 15.7 Billion by 2032 | Persistence Market Research

The global coronary stents market is set for robust expansion, with its value projected to increase from US$ 10.2 Bn in 2025 to US$ 15.7 Bn by 2032, advancing at a CAGR of 6.4% during the forecast period. This growth reflects rising procedural volumes driven by the global surge in cardiovascular disease prevalence, alongside rapid advancements in stent design and manufacturing technology. Drug-eluting and bioresorbable variants are at the forefront of this growth, benefiting from improvements in material science and precision engineering.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/3275

The drug-eluting stents (DES) segment is poised to dominate the market with a share of nearly 67.5% in 2025, supported by clinical efficacy in lowering restenosis rates. On the geographical front, North America leads with around 44.2% of the global share in 2025, attributed to early adoption of advanced technologies and favorable reimbursement structures. Meanwhile, Europe is expected to be the fastest-growing region due to supportive regulatory frameworks facilitating the approval of next-generation stents.

✦ Key Highlights from the Report

✦ The coronary stents market is forecasted to reach US$ 15.7 Bn by 2032 with a CAGR of 6.4%.
✦ North America leads the market with a 44.2% share in 2025, supported by robust reimbursement systems.
✦ Drug-eluting stents (DES) dominate the market, holding approximately 67.5% share in 2025.
✦ Outpatient facilities lead end-user adoption, with 58.3% share in 2025 due to minimally invasive PCI techniques.
✦ Europe emerges as the fastest-growing region with new regulatory approvals for advanced stents.
✦ Research trials show drug-coated balloons as an effective treatment for in-stent restenosis.

Market Segmentation Insights

The coronary stents market is segmented by product type and end-user category, each playing a distinct role in shaping adoption trends.

By Product Type, the market includes Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffolds (BVS). DES remain the gold standard due to their ability to minimize restenosis and reduce repeat interventions. Meanwhile, bioresorbable stents are gaining momentum by offering temporary vessel support and then gradually dissolving, restoring natural artery flexibility. These are particularly appealing for younger patients and those with complex anatomies.

By End-User, the market is divided into inpatient and outpatient facilities. Outpatient facilities dominate the share at 58.3% in 2025, as minimally invasive stent procedures and same-day discharge practices grow. However, inpatient facilities continue to handle complex cases, especially among elderly populations requiring prolonged monitoring and specialized interventions.

Read More In Detail: https://www.persistencemarketresearch.com/market-research/coronary-stents-market.asp

Regional Insights

North America remains the global leader, accounting for 44.2% market share in 2025. The U.S. in particular dominates due to widespread use of advanced DES, growing cardiovascular burden, and rapid adoption of drug-coated balloons for treating restenosis. Regulatory approvals, such as the FDA's clearance of the Agent Coronary Drug-Coated Balloon in 2024, reinforce the region's technological leadership.

Europe is identified as the fastest-growing region, benefitting from supportive regulatory frameworks that encourage the clinical use of next-generation stents. Recent approvals for devices like Biotronik's Orsiro Mission DES and Getinge's Advanta V12 covered stent are enabling broader application in complex cardiovascular cases. Furthermore, innovative devices such as Elixir Medical's DynamX bioadaptor reflect Europe's focus on precision-based solutions.

Asia Pacific is emerging as a growth powerhouse, led by China where local manufacturers supply more than 70% of stents used, thanks to government procurement initiatives and national insurance coverage. India is boosting accessibility with price caps, while Japan sustains demand through its aging population and universal healthcare framework. These dynamics make Asia Pacific one of the most competitive and innovation-driven regions in the forecast period.

Market Drivers

The primary driver of market growth is the global rise in Coronary Artery Disease (CAD) cases. Lifestyle changes, aging demographics, and rising rates of obesity, diabetes, and hypertension are fueling the need for interventional treatments. For instance, China alone conducts more than 1.2 million PCI procedures annually, most involving DES. Similarly, the U.S. continues to face high CAD prevalence, with over 20 million adults affected, according to the American Heart Association's 2024 update.

Market Restraints

One of the key challenges facing the coronary stents market is the issue of safety concerns and product recalls. Stent recalls can severely undermine physician confidence and delay procurement decisions. For example, Medtronic's 2023 voluntary recall of its Onyx Frontier DES due to delivery system defects led several hospitals to temporarily suspend new orders. Similarly, Abbott's withdrawal of the first-generation Absorb bioresorbable stent due to thrombosis concerns continues to affect perceptions of bioresorbable technologies.

Market Opportunities

The market is witnessing promising opportunities through 3D printing and personalized stents. Advanced additive manufacturing enables customized designs for patients with complex anatomies, improving fit and reducing risks such as restenosis. Research collaborations in Europe have already demonstrated the viability of 3D-printed bioresorbable stents in animal models, and commercialization is expected to follow once regulatory pathways adapt. This shift could redefine how stents are manufactured and deployed globally.

Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.persistencemarketresearch.com/request-customization/3275

# Frequently Asked Questions (FAQs)

How big is the global coronary stents market in 2025 and 2032?
Who are the key players in the global coronary stents market?
What is the projected growth rate of the coronary stents market?
What is the market forecast for coronary stents through 2032?
Which region is estimated to dominate the coronary stents industry during the forecast period?

Company Insights

• Abbott Laboratories
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• Terumo Corporation
• Stentys SA
• B Braun SE
• C. R. Bard, Inc.
• Biotronik
• Cook Medical
• Meril Life Sciences Pvt. Ltd.
• Biosensors International Group Limited

Recent Developments:

In August 2025, a subgroup analysis from the AGENT IDE trial revealed that paclitaxel-coated DCBs significantly reduced restenosis in patients with multilayer stent restenosis.

In May 2024, Abbott launched the XIENCE Sierra Everolimus-Eluting Coronary Stent System in India, expanding access to its latest-generation DES portfolio.

Conclusion

The coronary stents market is entering a dynamic growth phase, driven by the rising global burden of CAD, technological innovations, and expanding healthcare access in emerging economies. While safety concerns and recalls pose challenges, opportunities such as 3D-printed stents and novel drug-eluting technologies are poised to reshape the industry. With North America leading today and Asia Pacific emerging rapidly, the global landscape is set for both innovation and competition. Market leaders that continue to focus on advanced R&D and regional expansion will be best positioned to capture long-term growth in this evolving field.

Related Reports:

https://www.persistencemarketresearch.com/market-research/healthcare-companion-robots-market.asp
https://www.persistencemarketresearch.com/market-research/fertility-tourism-market.asp
https://www.persistencemarketresearch.com/market-research/therapeutic-contact-lenses-market.asp
https://www.persistencemarketresearch.com/market-research/facial-palsy-market.asp
https://www.persistencemarketresearch.com/market-research/near-infrared-imaging-market.asp

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.